Addison Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16
Closed -$353 748
2026
Q1
$353 Hold
16
﹤0.01% 949
2025
Q4
$189 Hold
16
﹤0.01% 880
2025
Q3
$254 Hold
16
﹤0.01% 866
2025
Q2
$184 Hold
16
﹤0.01% 860
2025
Q1
$217 Hold
16
﹤0.01% 815
2024
Q4
$271 Hold
16
﹤0.01% 819
2024
Q3
$326 Hold
16
﹤0.01% 812
2024
Q2
$362 Hold
16
﹤0.01% 749
2024
Q1
$421 Hold
16
﹤0.01% 675
2023
Q4
$505 Buy
+16
New +$434 ﹤0.01% 678
2023
Q1
Sell
-10
Closed -$306 652
2022
Q4
$306 Sell
10
-26
-72% -$780 ﹤0.01% 730
2022
Q3
$1K Buy
36
+26
+260% +$858 ﹤0.01% 592
2022
Q2
$0 Hold
10
﹤0.01% 678
2022
Q1
$0 Hold
10
﹤0.01% 711
2021
Q4
$0 Buy
+10
New +$312 ﹤0.01% 671

Other funds holding CC

Addison Advisors's CC Position: Q2 2026 in Review

Addison Advisors sold out of Chemours (CC) in Q2 2026, closing a stake of 16 shares — an estimated $353 sold.

Addison Advisors first reported a position in CC in Q4 2021 and held it in 15 quarters. The position peaked at $1K in Q3 2022. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Addison Advisors reported no remaining Chemours position as of Q2 2026 after selling out during the quarter.
  • Addison Advisors sold 16 Chemours shares in Q2 2026, an estimated $353.
  • Addison Advisors first reported a position in Chemours in Q4 2021 and held it in 15 quarters.
  • Addison Advisors's Chemours position peaked at $1K in Q3 2022.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.